Visual Universitätsmedizin Mainz

UCT Research Seminars



14.12.2017
Fachveranstaltung
Seminar in Translational Oncology: James Dahlman: "Measuring how thousands of nanoparticles deliver genetic drugs in vivo with DNA barcodes"
Veranstalter: TRON - Translational Oncology

09.11.2017
Fachveranstaltung
Seminar in Translational Oncology: Andreas Trumpp: "Stem Cell Programs during normal physiology and cancer"
Veranstalter: TRON - Translational Oncology

07.11.2017
Fachveranstaltung
MSU Oncology Seminar Series "New horizons in oncology", Johanna Ivaska: "Cell adhesion in cancer invasion and metastasis"
Veranstalter: Molecular Signaling Unit at the Research Center for Immunotherapy (FZI) and the University Cancer Center (UCT)

07.11.2017
Fachveranstaltung
MSU Oncology Seminar Series "New horizons in oncology", Johanna Ivaska: "Cell adhesion in cancer invasion and metastasis"
Veranstalter: Molecular Signaling Unit at the Research Center for Immunotherapy (FZI) and the University Cancer Center (UCT)

07.11.2017
Fachveranstaltung
New Horizons in Oncology: "Cell Adhesion in Cancer Invasion and Metastasis"
Veranstalter: Molecular Signaling Unit am Forschungszentrum für Immuntherapie (FZI); Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

07.11.2017
Fachveranstaltung
MSU Oncology Seminar Series "New horizons in oncology", Johanna Ivaska: "Cell adhesion in cancer invasion and metastasis"
Veranstalter: Molecular Signaling Unit at the Research Center for Immunotherapy (FZI) and the University Cancer Center (UCT)

14.09.2017
Fachveranstaltung
Seminar in Translational Oncology: Federico Garrido: "The escape of cancer from T cell mediated immune surveillance: HLA class-I loss and tumor tissue architecture"
Veranstalter: TRON-Translational Oncology

24.08.2017
Fachveranstaltung
Seminar in Translational Oncology: Evan Newell: "High-dimensional profiling of human antigen-specific T cells: Asking T cells what they 'see' in cancer"
Veranstalter: TRON - Translational Oncology

22.05.2017
Fachveranstaltung
MSU Oncology Seminar Series "New horizons in oncology", Walter Kolch: "From systems biology to systems medicine"
Veranstalter: Molecular Signaling Unit at the Research Center for Immunotherapy (FZI) and the University Cancer Center (UCT)

14.03.2017
Fachveranstaltung
Biomedical Research Seminars in Oncology: "Ubiquitination governs signaling pathways of RAS-like GTPases"
Veranstalter: Molecular Signaling Unit am Forschungszentrum für Immuntherapie (FZI); Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

09.03.2017
Fachveranstaltung
FZI Seminar Series: Christian Münz, Zürich: "Infection and immune control of a human tumor virus in vivo"
Veranstalter: Research Center for Immunotherapy (FZI)

09.02.2017
Fachveranstaltung
FZI Seminar Series: Averil Ma: “Regulating ubiquitination and disease"
Veranstalter: Research Center for Immunotherapy (FZI)

02.02.2017
Fachveranstaltung
FTN/FZI Seminar: Hartmut Wekerle, MD, Max Planck Institute of Neurobiology, "Genesis –on the initiation of MS”
Veranstalter: Focus Program Translational Neurosciences (FTN) & Research Center for Immunotherapy (FZI)

18.01.2017
Fachveranstaltung
Biomedical Research Seminar in Oncology:" The ubiquitin proteasome system - role in the pathogenesis, evolution and therapy of B-Cell malignancies"
Veranstalter: The Molecular Signaling Unit at the Research Center for Immunotherapy (FZI) and the University Cancer Center (UCT)

17.11.2016
Fachveranstaltung
Seminar in Translational Oncology: "The immune biology of microsatellite instability cancer: Towards a vaccine against HNPCC"
Veranstalter: TRON - Translational Oncology

10.11.2016
Fachveranstaltung
Seminar in Translational Oncology: "Inducing neoantigens in therapeutic and prophylactic cancer immunotherapy"
Veranstalter: TRON - Translational Oncology

10.11.2016
Fachveranstaltung
Biomedical Research Seminars in Oncology: "The Immune System: A Double-Edged Sword in Metastatic Breast Cancer"
Veranstalter: Molecular Signaling Unit at the Research Center for Immunotherapy (FZI) & University Cancer Center (UCT)

29.09.2016
Fachveranstaltung
Seminar in Translational Oncology: "Diabetes, beta-cells and reprograming with mRNA: potential cell-based therapy for diabetes"
Veranstalter: TRON - Translational Oncology

12.09.2016
Fachveranstaltung
Biomedical Research Seminars in Oncology: "Practical precision medicine in cancer using mitochondria"
Veranstalter: Molecular Signaling Unit at the FZI

08.09.2016
Fachveranstaltung
Seminar in Translational Oncology: "Characterizing mRNA-basedtherapeutics and vaccines: fromsingle molecules to the whole body"
Veranstalter: TRON - Translational Oncology

08.09.2016
Fachveranstaltung
FZI-Seminar: Hans-Reimer Rodewald, Heidelberg: “Cell competition and T-ALL: A subtle model of transforming normal progenitors”
Veranstalter: Research Center for Immunotherapy (FZI)

30.06.2016
Fachveranstaltung
FZI-Seminar: Jonathan Kipnis: "A fresh (immune) look at neurological disorders"
Veranstalter: Research Center for Immunotherapy (FZI

21.06.2016
Fachveranstaltung
Biomedical Research Seminars in Oncology: "Reactivating telomerase in cancer"
Veranstalter: Molecular Signaling Unit at the FZI

09.06.2016
Fachveranstaltung
Seminar in Translational Oncology: "Abrogation of the immunosuppressive tumor-microenvironment in Hepatocellular Carcinoma by targeting Treg and co-inhibitory pathways"
Veranstalter: TRON - Translational Oncology

02.06.2016
Fachveranstaltung
FZI-Seminar: "Function and origin of perivascular macrophages in inflammation and tumours"
Veranstalter: Research Center for Immunotherapy (FZI)

28.04.2016
Fachveranstaltung
Seminar in Translational Oncology: "Exploiting natural killer cells for immunotherapy of cancer"
Veranstalter: TRON-Translational Oncology

14.04.2016
Fachveranstaltung
FZI-Seminar: Stefan Bittner, Mainz: "K2P potassium channels regulate T cell development and immunity"
Veranstalter: Research Center for Immunotherapy (FZI)

12.04.2016
Fachveranstaltung
Biomedical Research Seminars in Oncology: "Dual targeting of senescence and tumor immunity for cancer therapy"
Veranstalter: Molecular Signaling Unit at the FZI

04.04.2016
Fachveranstaltung
UCT-MSU-Seminar "Global analysis of host and bacterial ubiquitinome in response to Salmonella typhimurium infection"
Veranstalter: Molecular Signaling Unit am Forschungszentrum für Immuntherapie (FZI); Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

09.03.2016
Fachveranstaltung
FZI-Seminar Yasmine Belkaid, NIH Bethesda, USA: “Microbiome Control of Tissue Immunity”
Veranstalter: Research Center for Immunotherapy (FZI)

03.03.2016
Fachveranstaltung
FZI-Seminar: Andreas Schlitzer, Bonn: Redefining myeloid cell development - one cell at a time
Veranstalter: Research Center for Immunotherapy (FZI)

25.02.2016
Fachveranstaltung
UCT-MSU-Seminar "Cryo-EM structural basis for dynactin-p150 binding to microtubules and its implication for microtubule dynamics"
Veranstalter: Molecular Signaling Unit am Forschungszentrum für Immuntherapie (FZI); Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

17.02.2016
Fachveranstaltung
UCT-MSU-Seminar "Tissue quality and clinical data: the bottleneck for drug and biomarker development"
Veranstalter: Molecular Signaling Unit am Forschungszentrum für Immuntherapie (FZI); Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

14.01.2016
Fachveranstaltung
Biomedical Research Seminars in Oncology: "Targeted cancer therapy and tumor heterogeneity: act locally, think globally"
Veranstalter: Universitäres Centrum für Tumorerkrankungen (UCT) Mainz, Forschungszentrum für Immunologie (FZI)

17.11.2015
Fachveranstaltung
Biomedical Research Seminars in Oncology: "Molecular Radiation Oncology: Biological approaches to improve the outcome of cancer radiotherapy"
Veranstalter: Universitäres Centrum für Tumorerkrankungen (UCT) Mainz, Forschungszentrum für Immunologie (FZI)

09.06.2015
Fachveranstaltung
FZI-Seminar David Vaux, Melbourne Autralia: “Targeting IAP and Bcl-2 family proteins to treat cancer”
Veranstalter: Research Center for Immunortherapy (FZI)

07.05.2015
Fachveranstaltung
FZI-Seminar: Yvette van Kooyk, Amsterdam: "Nanotechnology for the design of dendrtic cell targeting cancer vaccines"
Veranstalter: Research Center for Immunotherapy (FZI)

12.03.2015
Fachveranstaltung
FZI-Seminar: „Reprogramming of the tumor microenvironment for efficient tumor rejection”
Veranstalter: Research Center for Immunotherapy (FZI)

18.09.2014
Fachveranstaltung
Seminar in Translational Oncology: "Personalisation of cancer therapy"
Veranstalter: Translational Oncology at the University Medical Center (TRON)

03.07.2014
Öffentliche Veranstaltung
FZI-Seminar: "Epigenetic control of B-cell adaptive immunity and lymphomagenesis"
Veranstalter: Research Center for Immunotherapie (FZI)

10.04.2014
Fachveranstaltung
FZI-Seminar: "Inflammation & Cell Plasticity during Intestinal Tumorigenesis"
Veranstalter: Forschungszentrum Immunologie (FZI)

12.12.2013
Fachveranstaltung
FZI-Seminar: „Novel directions in dendritic cell based cancer immunotherapy“
Veranstalter: Forschungszentrum Immunologie (FZI)

14.11.2013
Fachveranstaltung
FZI-Seminar: "T cell-mediated immunity arrests cancer through superinduction of the p16Ink4a tumor suppressor."
Veranstalter: Forschungszentrum Immunologie (FZI)

13.06.2013
Fachveranstaltung
FZI-Seminar: "Peptide-based cancer immunotherapy."
Veranstalter: Forschungszentrum Immunologie (FZI)

44 Termine